|
Nalbuphine HclDrug - Nalbuphine Hcl The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Nalbuphine Hydrochloride
Strength -
10MG/ML
Applicant -
ASTRAZENECA
New Drug Application (NDA) Number -
072071
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Apr 10, 1989
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Astrazeneca Lp
Nalbuphine Hcl
Nalbuphine Hcl 20mg/ml Injectable; Injection
Nalbuphine Hcl 10mg/ml Injectable; Injection Nalbuphine Hcl 10mg/ml Injectable; Injection Unipen In Plastic Container Eq 1gm Base/vial Injectable; Injection Unipen Eq 500mg Base Tablet; Oral Naftin 1% Cream; Topical Naftin 1% Gel; Topical Nalbuphine 10mg/ml Injectable; Injection Nalbuphine 20mg/ml Injectable; Injection Nalbuphine Hcl 1.5mg/ml Injectable; Injection NewDrugInformation |